In the present study, we tested whether apoptotic neuronal death caused by withdrawal of trophic support might be prevented by agents that block cell cycle progression.
In the present study, we tested whether apoptotic neuronal death caused by withdrawal of trophic support might be prevented by agents that block cell cycle progression.
We used three complementary model systems that exhibit apoptotic death: dividing PC12 cells deprived of serum; nondividing, neuronally differentiated PC12 cells deprived of nerve growth factor (NGF); and primary cultures of postmitotic sympathetic neurons deprived of NGF. We show that cell death in each case can be suppressed by treatment with the Gl/S blockers mimosine, ciclopirox, and deferoxamine at concentrations that correlate with their abilities to block PC12 cell proliferation.
In contrast, agents that block cell cycle progression in the S-, G2-, or M-phase do not prevent cell death. These observations support the hypothesis that removal of trophic support from dividing or postmitotic neuronal cells provokes their apoptotic death by causing them either to proceed through or to attempt to re-enter an uncoordinated and consequently fatal cell cycle. Moreover, the data suggest that simply blocking the cycle at any point is not protective but, rather, that it is necessary to block at specific "safe" points. This study defines a safe point in the cell cycle before the Gl/S transition that is demarcated by the action of these three agents.
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The mechanisms by which nerve growth factor (NGF) and other neurotrophic agents promote neuronal survival are currently unresolved. Cultured sympathetic neurons deprived of NGF undergo apoptotic death (Edwards et al., 1991; Batistatou and Greene, 1993; Deckwerth and Johnson, 1993; Edwards and Tolkovsky, 1994) and have been valuable for investigating mechanisms of survival and death (Deckwerth and Johnson, 1993; Edwards and Tolkovsky, 1994; Greenlund et al., 1995) . The PC12 rat pheochromocytoma cell line (Greene and Tischler, 1976 ) also has been used as a model to study the mechanism of apoptotic neuronal death after withdrawal of trophic support. In serum-containing medium, PC12 cells divide and display many characteristics of adrenal chromaffin cells. Within several days of NGF exposure, these cells stop dividing and acquire numerous properties of mature sympathetic neurons (for review, see Greene and Tischler, 1982; Guroff, 1985) . When cultured in serum-free medium without NGF, both naive and neuronally differentiated (NGF-pretreated) PC12 cells die via an apoptotic mechanism (Greene, 1978; Batistatou and Greene, 1991) . The addition of NGF to the cells in serum-free medium rescues them from death. Because both naive proliferating and neuronally differentiated nonproliferating PC12 cells are sustained by NGF under serum-free conditions, the line may be used to model the survival mechanisms of both neuroblasts and postmitotic neurons.
Studies with neuronally differentiated PC12 cells reveal that, as with sympathetic neurons (Martin et al., 1988) , death caused by withdrawal of trophic support is retarded by RNA and protein synthesis inhibitors (Mesner et al., 1992; Pittman et al., 1993) . In contrast, such inhibitors do not prevent the death of naive PC12 cells (Rukenstein et al., 1991) . We suggest that this difference in behavior illuminates the underlying role of NGF and other trophic agents in promoting cell survival. For dividing neuroblast-like naive PC12 cells, we hypothesize that trophic factors such as NGF are required for successful cell cycle traverse and that in the absence of such support, an abortive and fatal cycle occurs (Batistatou and Greene, 1993; Ferrari and Greene, 19Y4; Greene et al., 1995a,b) . This proposal is supported by a number of recent findings with non-neuronal cells (Yonish-Rouach ct al., 1901 , 1993 Colombel et al., 1992; Evan et al., 1992; Shi et al., 1994) . In the case of neuroblasts, cell cycle molecules are constitutivcly expressed; hence, attempted replication and death are independent of synthesis. In contrast, for nondividing neurons and NGFpretreated PC12 cells, we propose that RNA and protein synthesis blockers prevent neuronal death because they suppress the production of proteins required for attempted cycle re-entry (Ferrari and Greene, 1994; Greene et al., 1995a,b) . In consonance with this, long-term NGF exposure exerts antimitogenic actions on PC12 (Greene and Tischler, 1976; Ferrari and Greene, 1994) and chromaffin cells (Tischler et al., 1993) . Also, Freeman ct al. (1994) reported that the Gl cyclin Dl is induced during the death of NGF-deprived sympathetic neurons, and Brooks ct al. (1993) 
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Chlorphenylthio (CPT)-CAMP blocks both PC12 cell cycle progression
and death Previous findings demonstrated that the CAMP analog CPT-CAMP prevents the death of trophic factor-deprived PC12 cells and neurons (Rydel and Greene, 1988; Rukenstein ct al., 1YYl) . To examine whether this effect is related to the cell cycle, we tested the ability of CPT-CAMP to prevent DNA replication in serum-containing medium in parallel with its ability to prevent the death of serum-deprived PC12 cells. In the typical assay for serum-free survival, 6575%
of PC12 cells die after 1 d and virtually all die after 4 d. As shown in Figure I , there is a close correlation of the dose-response relationships between the ability of CPT-CAMP to inhibit thymidine incorporation and to promote the survival of PC12 cells in serum-free medium. CPT-CAMP acts rapidly to block DNA synthesis; within 2 hr of treatment with IOU FM CPT-CAMP, [3H]thymidine incorporation is blocked by 75%~, and inhibition is complete by 24 hr. As demonstrated previously, it is not necessary to pretreat PC12 cells with CPT-CAMP before serum deprivation to obtain complete survival (Rukcnstein et al., 1991) . The finding that CPT-CAMP causes cessation of PC12 cell proliferation and promotes survival prompted us to examine further the prediction that blocking cell cycle progression may prevent cell death after trophic factor withdrawal.
We therefore tested a battery of agents that block cell cycle transit at specific points for their ability to prevent the death of trophic factordeprived PC12 cells and sympathetic neurons. All agents first were tested for their ability to block the incorporation of [-'HIthymidine into DNA so that the in the experiments we would use appropriate concentrations and lengths of pretreatment.
The Gl/S blockers mimosine, CPX, and deferoxamine prevent the death of serum-deprived PC12 cells Mimosinc is an agent that blocks cells before the Gl/S transition point via a mechanism that is still undetermined (Lalande, 1990) (set Discussion). This drug blocks thymidine incorporation completcly in dividing PC12 cells within 4 hr at concentrations of 300-400 PM ( Fig. 24 ) (time course of inhibition not shown). As shown in Figures 2A and 3 , mimosinc prevented the death of serum-deprived PC12 cells in a concentration-dependent manner and was maximally effective at 400 PM. Comparison of the curves in Figure 2A reveals a close correlation between the concentration of mimosine required to inhibit DNA synthesis and the concentration required to prevent the death of serum-deprived PC12 cells. Unlike rescue by CPT-CAMP and other survival factors, it was necessary to pretreat cells with mimosine overnight before serum deprivation to obtain complete survival (Fig. 2B) . Figure  2C illustrates the long-term effects of mimosine treatment on smvival in this paradigm. Survival up to 3 d was excellent (>85%1); however, mimosine was unable to promote full survival beyond this time. This seemed to be attributable to toxicity, because even when NGF was present in combination with mimosine thcrc was a comparable loss of cell viability.
Deferoxamine is thought to block cellular proliferation bcforc the Gl/S transition by chelating intracellular iron (Brodie et al., 1993) . Deferoxamine inhibits DNA synthesis in proliferating PC12 cells in a concentration-dependent manner (Fig. 4A) . Trcatment with 1 mM deferoxamine completely blocked thymidine incorporation after 4 hr. As with mimosine, thcrc is a concentration-dependent increase in the survival of serumdeprived PC12 cells that reaches the maximum at I mM dcferoxamine, the concentration at which DNA synthesis is completely abolished. As shown in Figure 4B , deferoxamine treatment produces good short-term survival in this paradigm compared with survival in untreated cultures. After long-term exposure, howcvcr, deferoxamine, like mimosinc, proves toxic to the cells hccause viability cannot be maintained even when NGF is provided in combination.
Overnight pretreatment enhances the protective effect of deferoxamine on serum-deprived PC12 cells (Fig. 4C ). Deferoxamine-treated cells deprived of serum for I d arc shown in Figure 30 .
CPX blocks cells at the same point near the Gl/S border as does mimosine, but its mechanism of action is unknown (Hoffman et al., 1991) . CPX inhibits thymidine incorporation in PC12 cells with an ICs,, of -1.5 pM in serum-free medium and an IC,,, of -5 PM in medium containing 15%' serum. In serum-free medium, there was a reproducible increase in ['Hlthymidine incorporation with 1 PM CPX before the steep decline; at 2 FM CPX, inhibition of DNA synthesis was virtually complete (Fig. SA) . After overnight pretreatment of PC12 cells growing in serum-containing medium with 10 FM CPX, the drug was able to promote nearly complete survival 24 hr after serum deprivation, and it did so at concentrations similar to those required to inhibit [-'Hlthymidinc incorporation (Fig. 5A ). As with mimosinc and defcroxaminc, it was necessary to pretreat cells with CPX bcforc serum deprivation to obtain maximal survival. Figure 5B depicts the time course of the effects of CPX treatment on survival in this paradigm. Survival was good up to 2 d after serum deprivation (~75%) survival); however, CPX was unable to maintain good long-term survival. This seemed to be attributable to the toxicity of the drug, because even when NGF was present in combination with CPX thcrc was a similar loss of cell viability.
In addition to cell counting, several independent methods were used to confirm the viability of the cells treated with the GliS blockers. These are presented in Figure 6 . Cultures were main tained in serum-free medium with mimosine for 1 d and then washed free of the drug and returned to medium containing 15% serum. Under these conditions, after a lag phase for the cells that had been maintained by mimosine, proliferation recommenced, thus providing a clear indication of viability (Fig. &I) . The lag phase presumably reflects the time required for the drug to bc cleared from the cells. We also used the vital indicator Alamnr Blue, a dye that is reduced by living cells, to examine the extent of cell survival. The data in Figure 68 indicate that by this criterion all three Gl/S blockers maintained full cell viability in strum-free medium. In addition, nuclear morphology of serum-deprived PC12 cells (exposed to no additive, NGF, CPX, mimosine, or deferoxamine for 24 hr) was visualized using the stain Hoechst 33342. Quantitation of normal and pyknotic nuclei provided rcsuits similar to those achieved by the counting of intact nuclei. In this assay, the proportions of cells with pyknotic nuclei (II = 
100-200 nucleiitrcatment)
were as follows: 5h%, no additive; 9%, NGF; 9%, CPX; 1 I%, deferoxamine; and 1 I%, mimosine.
Because mimosine is an amino acid and was used at relatively high concentrations, we determined whether this agent might prevent cell death by interfering with protein synthesis. The data in Figure 6C show that mimosine does not inhibit protein synthesis by >IS-20% in either PC12 cells or primary sympathetic neurons at concentrations up to 800 pM. Martin et al. (1992) reported that cell death was prevented by cycloheximide in NGFdeprived sympathetic neuron cultures only when protein synthesis was blocked by ~80%. Thus, mimosine does not promote survival by inhibiting protein synthesis.
S-, G2-, or M-phase blockers do not prevent the death of serum-deprived naive PC12 cells The three S-phase blockers chosen for these studies inhibit distinct enzymes necessary for DNA synthesis: aphidicolin inhibits DNA polymerase-rr (Ikegami ct al., 1978); 5fIuorodeoxyuridine inhibits thymidylatc synthetase (Jackson, 1978) ; and hydroxyurea blocks ribonucleotide reductase (Adams and Lindsay, 1967) . We used the following concentrations:
IO PM aphidicolin, 10 pM 5fluorodeoxyuridine, and 3 mM hydroxyurea. At these concentrations. DNA synthesis was inhibited >9S% after 3 hr. None of the S-phase blockers, however, were able to prevent the death of serum-dcprivcd PC12 cells (Fig. 7A) . These blockers were ineffective regardless of the length of the pretreatment period (up to 3 d before serum withdrawal; data not shown). Addition of NGF to the cultures maintained their survival in the presence of the inhibitors, indicating that the drugs themselves did not cause cell death.
The topoisomerase inhibitor VM-26 blocks cells in the G2-phase of the cell cycle (Roberge et al., 1990; Chen and Beck, 1993) . Nocodazole and taxol, agents that inhibit and stabilize polymerization of microtubules, respectively, block cells in mitosis (Schiff ct al., 1979; Wilson and Jordan, 1994) . Each of these agents blocks DNA synthesis but, in contrast to the other agents used here, the M-phase inhibitors required 2 d of pretreatment before causing complete inhibition of thymidine incorporation. This was expected because the PC12 cell cycle lasts -2.5 d, with the M-phase taking only a small fraction of that. Preliminary invcstigations revealed that the concentrations of VM-26, nocodazole, and taxol required to block DNA synthesis were 1 PM, 200 nM, and 500 nM, respectively. As with the S-phase blockers, G2-phase and mitotic inhibitors failed to prevent the death of PC12 cells after serum withdrawal (Fig. 7B ). These blockers were ineffective regardless of the length of pretreatment (up to 3 d: data not shown). In this paradigm, NGF substantially prevented the death of PC12 cells in the presence of the inhibitors. The capacity of NGF to rescue cells blocked in the S-, G2-, or M-phase contrasts with the suggestion that NGF actions arc limited to a particular phase of the cell cycle (Rudkin et al., 1989) .
Mimosine, deferoxumine, and CPX prevent the deuth of neuronal PC12 cells after remowl of NGF
We next tested whether cell cycle blockers prevented the death of PC12 cells that were neuronally differentiated by long-term treatment with NGF in serum-free medium and then deprived of the factor. After several days in serum-free medium with NGF, PC12 cells stop dividing and acquire many of the phenotypic properties of sympathetic neurons (Greene and Tischler, 1982) . Strum-deprived neuronal PC12 cells, like sympathetic neurons, die after NGF withdrawal, with -SO-60%) of the cells dead after 2 d. The addition of 400 pM mimosinc, 1 mM deferoxaminc, or 1.5 pM CPX to cultures of ncuronal PC12 cells after the cells were washed free of NGF caused nearly complete survival for up to 2 d and -80% survival at 3 d. In contrast. only 25% of untreated cells remained viable at the latter time (Fig. 8) . After 2-3 d in the absence of NGF, there was a gradual decrease in the number of cells maintained by the three drugs. This seemed to be attributable to the toxic efkcts of thcsc agents (Fig. 8) . Unlike naive PC12 cells deprived of serum, it was not ncccssary to prctrcat neuronal PC12 cells with mimosinc or deferoxamine before NGF withdrawal to obtain complctc survival. In the absence of NGF, these three agents did not promote neurite regeneration-nor did they prevent this process in the presence of NGF (data not shown).
S-, G2-, or M-phase blockers do not prevent the death of neuronal PC12 cells after the removal of NGF
We proceeded to test the ability of the other cell cycle blockers to prevent the death of NGF-deprived neuronal PC12 cells. The data in Figure 7 , C and D, show that S-, G2-, or M-phase blockers do not rescue these cells from death. Cells treated with S-phase blockers die at the same rate as untreated controls do, whereas cells that received NGF in addition to the inhibitor were mostly protected (Fig. 7C) . Figure 70 shows basically the same outcome with G2-and M-phase inhibitors. Two days after NGF removal, roughly the same fraction of cells died, despite the presence of these agents. NGF rescued the cells from death under all conditions, demonstrating that the inhibitors themselves were not toxic in this paradigm. None of the inhibitors was able to prevent cell death, even when the cultures were pretreated up to 3 d before NGF withdrawal (data not shown).
Primary sympathetic neurons
Gl blockers mimosine, deferoxamine, and CPXprevent the death of sympathetic neurons after removal of NGF, whereas S-, G2-, and M-phase blockers do not Our observations with neuronal PC12 cells indicate that mimosine, deferoxamine, and CPX prevent the death of cells that are nonmitotic at the time of NGF withdrawal. To extend these observations to a postmitotic neuronal model, we next examined the effects of cell cycle blockers on NGF-deprived sympathetic neurons. In this paradigm, sympathetic neurons from 2-d-old rats were cultured in the presence of NGF for 6 d (or 3 d in the CPX experiments) and then deprived of the factor. Under these conditions, -5O-60% of the neurons die within 48 hr and virtually all die by 5 d. The addition of mimosine, deferoxamine, or CPX to cultures of sympathetic neurons immediately after NGF withdrawal rescued them from death (Figs. 9, 10) incorporation (4) was conducted after a 24 hr pretreatment with deferoxamine. B, Time course of survival in serum-free conditions: (Cl) no additives; (W) NGF; ( 0 ) 1 mM dcferoxamine; ( + ) 1 mM deferoxamine + NGF. C, Pretreatment with deferoxamine enhances its protective effect on serum-deprived PC12 cells. Pretreated cells were exposed to 1 IIIM deferoxamine for 16 hr before serum deprivation: a indicates significantly greater than untreated control 07 i 0.05); h indicates significantly less than deferoxamine-pretreated cultures (p < 0.05). All data are the mean i SEM of three samples.
possibility that the mechanism of rescue is similar in the two systems. After 3 d of deprivation, -80% of the mimosine-treated neurons, 90% of the deferoxamine-treated neurons, and >95% of the CPX-treated neurons retained a phase-bright, viable appearance compared with ~2.5% of their untreated counterparts. Although the neurons in cultures treated with these agents showed loss of somal volume, they maintained their neurite network in the absence of NGF, in contrast to the dying, untreated controls (Fig.  10) . As shown in Figure 6C , the effect of mimosine was not attributable to suppression of protein synthesis. Although both agents maintained survival, they did not promote somatic hypertrophy as did NGF (Fig. 1OB) . Viability of the neurons began to AI T --t % thymidine incorporation * relative % survival decline after 3 d in the presence of either agent. As with PC12 cells, this seemed to be attributable to a long-term toxic action of these agents, because the cells die even it' NGF is present in combination with these drugs (Fig. 9 ,4-C). This toxicity was concentration-dependent (data not shown). To verify that the neurons maintained by the Gl/S blockers were indeed viable, the drugs were removed and NGF was added to the cultures again. As observed by microscopic inspection, removal of the blockers and addition of NGF were accompanied by the return of somatic hypertrophy and by renewed outgrowth of the neuritic network. Moreover, as shown in Figure 9D As illustrated in Figure YE , treatment of sympathetic neurons with S-, G2-, and M-phase blockers did not effectively rescue them from death after NGF withdrawal. These blockers were not toxic to the neurons, because viability was maintained when NGF was present in combination.
DISCUSSION
We demonstrate here that mimosinc, CPX, and defcroxamine inhibit death of trophic factor-deprived PC12 cells and sympathctic neurons. These findings, therefore, identify several small compounds that interfere with induced neuronal death and provide potential insight into the mechanisms by which trophic agents regulate neuronal survival and apoptosis.
The capacity of Gl/S blockers to maintain survival was confirmed by several different criteria. For PC12 cells, quantification of intact nuclei, which has proved a highly reliable indicator of survival in previous studies (Batistatou and Greene, I991 ; Rukenstein et al.. IYYI), was supplemented by demonstrating intact metabolic function with Alamar Blue, showing that ccl1 rcplication commenced after drug washout and addition of serum, and differentially staining intact and pyknotic nuclei with Hoechst 3.3342. In the case of sympathetic neurons, ccl1 survival was assessed by the presence of intact, phase-bright somas and maintenance of the ncuritic network, as well as by the observation that drug washout and NGF re-addition led to the rcappcarance of ncurite outgrowth and somatic hypertrophy. Moreover, a majority of cells scored as viable in the presence of the GUS inhibitors were still identifiable as such scvcral days after the drugs were removed and replaced with NGF.
One mechanism that might account for the protective effects of mimosine, CPX, and dcferoxamine is their action as cell cycle inhibitors. We have hypothesized that trophic factors such as NGF promote survival by guiding proliferating neuroblasts through the cell cycle, by causing neuroblasts to ditfcrentiate and leave the cycle, or by causing postmitotic neurons to remain out of the cycle (Ferrari and Greene, 194; Greene ct al., lYYSa.b). We and others have postulated further that neuroblast-like cells die after loss of trophic support because they undergo an aborted attempt to proliferate, and that withdrawal of trophic factors from postmitotic neurons causes apoptotic death attributable to an inappropriate attempt to re-enter the cell cycle (Batistatou and Grcenc, 1003; Heintz, 1093; Rubin et al., IYY3; Fcrrari and Grccnc, IYY4; Freeman et al., lYY4; Greene ct al., lYYSa,b) . This model predicts that appropriately blocking neuronal cells from entering or rcentering the cell cycle should protect them from death caused by loss of trophic support. In accordance with this, blockade of DNA synthesis by induction of dominant-inhibitory ~1s in both naive and primed PC12 cells (Ferrari and Greene, lYY4) or by treatment of PC12 cells and sympathetic neurons with N-acetylcysteinc (Ferrari et al., lYY5) promotes long-term survival after trophic factor withdrawal.
Our experiments further support and cxtcnd these findings.
One question that was answered here is whether blockade at any stage of the cell cycle is sufficient to prevent death of trophic factor-deprived neuronal cells. Clearly, our findings indicate that this is not the case. S-, G2-, or M-phase blockers wcrc unable to delay or prevent death. Only GI/S blockers were cflcctivc in this respect. This suggests that there is a cell cycle checkpoint downstream of or at the point where these agents block (i.e., near the GUS border) that, once passed, commits neuronal culls to die in the absence of trophic support. CAMP is also an e#cctivc Gl blocker (Boynton and Whitfield, 1983 ; Kato ct al., lYY4), and our observed close correspondence between the dose-response curves for inhibition of DNA synthesis and promotion of survival by CPT-CAMP also supports this idea.
We used three complementary neuronal death models: proliferating naive PC12 cells, nonproliferating neuronally ditferentiatcd PC12 cells, and postmitotic sympathetic neurons. Several points that support the above interpretation cmcrge from com- parison of the three systems. First, the dose-response relationneurons. This difference is in agreement with the prediction of a ships for cell cycle blockade by mimosine, CPX, and deferoxamine critical checkpoint before the Gl/S border. Without drug prein naive PC12 cells correlate well with the abilities of these drugs treatment, naive PC12 cells are unsynchronized, and at the time of to rescue all three ccl1 types from death. This not only supports a trophic factor withdrawal, portions of the PC12 cells arc in the S-, link between cell cycle and neuronal death, but it is also consistent G2-, or M-phase. Our findings indicate that cells allowed to enter with a mechanism by which neuronally differentiated PC12 cells these portions of the cycle die when deprived of trophic support. and sympathetic neurons reenter the cell cycle after withdrawal
On the other hand, with a pretreatment period with Gl/S blockof trophic support but are prevented by these agents from fatally ers, the cells have the time to continue progression so that they progressing. Second, complete rescue of naive PC12 cells by the return to GI where they are then trapped in a safe position before Gl blockers requires overnight pretreatment before serum deprithe critical checkpoint. Thus, as observed, pretreatment is necesvation, whereas such pretreatment is not necessary for complete sary for complete rescue of naive cells from serum withdrawal. In rescue of neuronally differentiated PC12 cells or sympathetic this case of sympathetic neurons and ncuronally dilfcrcntiated 1, 1996, 76(3):1150-1162 on NGF-primed PC12 cell survival after removal of NGF in serum-free medium: (0) PC12 cells, the cells are already essentially synchronized in G, in the presence of NGF, and pretreatment is therefore unnecessary for complete rescue by GUS blockers.
The above interpretations are supported further by observations regarding apoptosis of mature T lymphocytes induced by T cell receptor (TcR) agonists. Susceptibility to TcR agonists occurs only when T cells are induced to proliferate by growth factors such as interleukin (IL)-2 (Lenardo, 1991) . Boehmc and Lenardo (1993) reported that IL-2-treated mature T lymphocytes were rescued from TcR-induced apoptosis by the Cl inhibitors mimosine, deferoxamine, and dibutyryl CAMP but not by the S-phase inhibitor aphidicolin.
The mechanisms by which mimosine and deferoxamine block proliferation are unclear, but it seems that their ability to chelate metal ions is critical. Mimosine is a plant amino acid that chelates copper and iron (Hashiguchi and Takahashi, 1977; Kontoghiorghes and Evans, 1985) . It reversibly inhibits the metallo-enzyme deoxyhypusyl hydroxylase, thus preventing the formation of hypusine, an essential component of the eukaryotic initiation factor 5A (Hanauske-Abel et al., 1994) . There is evidence for a correlation between hypusine formation and cell cycle progression (Park et al., 1993) . It also has been reported that mimosine causes a decrease in cyclin A/~34'"'~ kinase activity (Carbonaro-Hall et al., 1993; Feldman and Schonthal, 1994) as well as in the corresponding mRNAs for cyclin A and p34"rc2 (Feldman and Schonthal, 1994) . Deferoxamine is a microbial siderophore that has a high affinity for iron. Proliferating cells have an essential requirement for iron, and iron chelators such as deferoxamine block DNA synthesis (Robbins and Pederson, 1970; Ganeshaguru et al., 1980) and halt the cell cycle before the Gl/S boundary (Terada et al., 1991) . Deferoxamine also prevents the synthesis of P34 cd" in both lymphocytes and neuroblastoma cells (Brodie et al., 1993; Terada et al., 1993) . The mechanism by which CPX blocks cell cycle progression is not known (Hoffman et al., 1991) . It is used clinically as a topical antifungal agent, and its action in this respect may involve disruption of membrane function in sensitive organisms (Jue et al., 1985) . Because of its structural similarity with mimosine, the possibility that CPX chelates metal ions and/or inhibits hypusine formation cannot be excluded, although no such evidence has been reported (Hoffman et al., IYYl; Hanauske-Abel et al., 1994) . Because mimosine and deferoxamine are metal chelators, it is prudent to consider the possibility that they promote survival by inhibiting the formation of reactive oxygen species (ROS). There is reason to consider possible links between oxidative stress and neuronal apoptosis caused by trophic factor withdrawal. Grcenlurid et al. (1995) reported that there is a transient increase in ROS in sympathetic neurons within hours of NGF withdrawal. Moreover, the latter found that microinjection of copper/zinc superoxide dismutase (SOD) protein or expression vector delayed death of neurons deprived of NGF, whereas injection of antisense SOD accelerated neuronal death. Because re-addition of NGF was able to rescue NGF-deprived sympathetic neurons at a point after which injection of SOD cannot, it was suggested that generation of ROS signals downstream events in neuronal programmed cell death (Greenlund et al., 1995) . In additional studies, it was observed that trophic agents can protect neurons from conditions that cause oxidative stress, that such agents enhance metabolic pathways by which neurons cope with oxidative stress (Boniece and Wagner, 1993; Pan and Perez-Polo, 1993) and that overexpression of bcl-2 provides protection from both oxidative stress (Kane et al., 1993) and loss of trophic support (Garcia et al., 1992; Batistatou et al., 1993; Mah et al., 1993) . In addition, Ratan et al. (1994a,b) showed that inhibitors of protein and RNA synthesis protect neurons from apoptosis caused either by withdrawal of growth factors or by induction of oxidative stress by shunting intracellular use of cysteine from protein synthesis to that of glutathione, a major component in cellular protection from oxidative stress. Taken together, these considerations raise the possibility that ROS plays a role in the mechanism by which trophic factor deprivation leads to neuronal apoptosis. Moreover, it is even conceivable that ROS plays a role in signaling re-entry into the cell cycle (Ferrari et al., 1995 that tend to disfavor the likelihood that mimosine and deferoxamine protect neurons from growth factor withdrawal by suppressing oxidative stress. First, antioxidants such as vitamin E, butylated hydroxyanisole, and vitamin C, which prevent death induced by oxidativc stress in a variety of cell systems (Sies, 1993; Greenspan and Aruoma, 1994) fail to rescue PC12 cells from trophic factor withdrawal (Ferrari et al., 1995) . Particularly germane is the finding that SODI depletion in PC12 cells leads to their rapid apoptotic death, presumably via an oxidative stress mechanism (Troy and Shclanski, 1994) . In this case, low concentrations of vitamin E effectively prevent death, whereas long-term NGF exposure does not. Furthermore, although mimosine and deferoxamine prevent the death of PC12 cells in the SOD1 depletion model, they do so at concentrations that are orders of magnitude lower than those required to block apoptosis and DNA synthesis in the presently studied trophic factor withdrawal paradigm (Troy et al., 1996) . These considerations, therefore, indicate that PC12 cell death caused by oxidative stress and by trophic factor removal proceed, at least initially, by separate pathways. The necessary role for oxidative stress in programmed cell death is questioned further by the finding that in certain model systems, including one involving trophic factor deprivation, generation of ROS does not seem to be required for apoptotic death (Jacobson and Raff, 1995) . In summary, we have shown that mimosine, deferoxamine, CPX, and a permeant CAMP analog show good correlation between the concentrations necessary to block DNA synthesis and those necessary to suppress apoptotic death of neuronal cells caused by withdrawal of trophic support. This supports the hypothesis that neuronal cells die when deprived of trophic factors because they attempt abortive cell cycle progression, and it draws particular attention to a critical checkpoint at or before the G l/S border. Although apparently less likely, an alternative is that these agents protect trophic factor-deprived cells from death by their capacities to chelate iron and thereby prevent formation of ROS. In either case, mimosine, defcroxamine, and CPX represent promising classes of agents that might be developed further to prevent neuronal death in a clinical context and to dissect the mechanisms by which trophic factors regulate neuronal survival.
